Results Healthcare Appoints Anthony Harrington as Manager
News Aug 08, 2013
A graduate of National University Cork, Ireland, where he achieved a First in Business Economics and a BSc, Finance, First Class, Anthony most recently worked as a corporate finance consultant for Survitec Group and Enteq Upstream PLC. Prior to this he was Associate Director in the corporate finance department of Investec PLC. During his time at Investec, Anthony was involved in a number of significant transactions, including the sale of Arena Leisure PLC, the IPO of and subsequent fundraising for Enteq Upstream PLC, as well as acquisitions for Enteq and a fundraising for Digital Barriers PLC.
Before joining Investec, Anthony spent four years in the healthcare team at Rothschild. Here he worked on a wide variety of transactions, such as the sale of a minority stake in an Irish probiotics company, the private placement of a minority stake in an Indian pharmaceutical manufacturer, the acquisition by BTG PLC of Protherics PLC, the disposal of a non-core product portfolio by Shire PLC to Almirall and the sale of Huntleigh PLC to Getinge.
Anthony has a further two years healthcare experience, having worked as an Analyst with the healthcare team at Bear Stearns.
"We are pleased to welcome Anthony to our expanding healthcare team," commented Results Healthcare Managing Director, Kevin Bottomley. "His extensive healthcare experience and broad industry knowledge will further add to the skill set that we have within the Results Healthcare organisation."
Evolution Threatens Efficient Bioproduction Scale-UpNews
The transition towards sustainable biobased chemical production is important for green growth, but productivity and yield of engineered cells frequently decrease in large industry-scale fermentation. According to a new study, the role of evolution has been underestimated in limiting bioprocesses.
Sequencing Shows How Evolution Can Undermine Bioprocess CommercializationNews
Rapid evolution can suppress the effect of pro-production genes in biochemical processes.READ MORE
Lonza Expands Encapsulation and HPAPI Capabilities in North AmericaNews
Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.READ MORE
Comments | 0 ADD COMMENT
World Advanced Therapies & Regenerative Medicine Congress
May 16 - May 18, 2018
2nd International Conference on Food Science and Bioprocess Technology
Oct 01 - Oct 03, 2018